OAKLAND, Calif. (November 27, 2017) – TMG Partners, one of the Bay Area’s largest mixed-use property developers, announced today that biopharmaceutical company Clovis Oncology (NASDAQ: CLVS), an innovator in cancer drugs, signed a ten-year lease for 32,000 square feet at the developer’s 1330 Broadway property in Downtown Oakland. Clovis is expanding its footprint from Mission […]
The post TMG Partners Sign Clovis Oncology to 10-Year Lease for 32,000 SQFT at 133O Broadway in Oakland appeared first on The Registry.